A phase II open-label multicenter study to assess the efficacy and safety of AFM13 in patients with relapsed or refractory CD30 positive peripheral T-cell lymphoma or transformed mycosis fungoides: The REDIRECT study design and rationale.
AFM-13
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase II open-label multicenter study to assess the efficacy and safety of AFM13 in patients with relapsed or refractory CD30 positive peripheral T-cell lymphoma or transformed mycosis fungoides: The REDIRECT study design and rationale. ### Output: AFM-13